{"title":"Decoding Occult Cervical Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: From AI-Driven Multimodal Fusion to Clinical Translation.","authors":"Yun Lin, Ehab Hanna, Xinliang Pan, Guojun Li, Jeffrey N Myers","doi":"10.1007/s11912-026-01802-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>This review examines the limitations of conventional macroscopic approaches in detecting occult cervical lymph node metastasis (OCLNM). It also explores how multi-omics technologies and artificial intelligence (AI) driven cross-scale multimodal integration are reshaping precision diagnosis for patients with clinically node-negative (cN0) head and neck squamous cell carcinoma.</p><p><strong>Recent findings: </strong>Recent studies show that combining high-throughput omics data, such as genome-wide DNA methylation and spatial transcriptomics, with radiomics through deep learning models leads to markedly better performance than conventional imaging alone. New computational strategies, including habitat radiomics and cross-modal fusion networks, allow more detailed characterization of spatial tumor heterogeneity. They also provide insights into how the tumor microenvironment evolves during early metastatic spread. In addition to improving detection of microscopic disease, these approaches are beginning to support more reliable survival risk stratification. The integration of AI with multi-omics data is moving the field toward a noninvasive \"panoramic virtual biopsy.\" This framework offers a practical path to address a long-standing clinical challenge, balancing overtreatment against undertreatment in cN0 patients. With further validation, it may support safer surgical de-escalation and enable more personalized treatment strategies.</p>","PeriodicalId":10861,"journal":{"name":"Current Oncology Reports","volume":"28 1","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2026-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13236798/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Oncology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11912-026-01802-6","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose of review: This review examines the limitations of conventional macroscopic approaches in detecting occult cervical lymph node metastasis (OCLNM). It also explores how multi-omics technologies and artificial intelligence (AI) driven cross-scale multimodal integration are reshaping precision diagnosis for patients with clinically node-negative (cN0) head and neck squamous cell carcinoma.
Recent findings: Recent studies show that combining high-throughput omics data, such as genome-wide DNA methylation and spatial transcriptomics, with radiomics through deep learning models leads to markedly better performance than conventional imaging alone. New computational strategies, including habitat radiomics and cross-modal fusion networks, allow more detailed characterization of spatial tumor heterogeneity. They also provide insights into how the tumor microenvironment evolves during early metastatic spread. In addition to improving detection of microscopic disease, these approaches are beginning to support more reliable survival risk stratification. The integration of AI with multi-omics data is moving the field toward a noninvasive "panoramic virtual biopsy." This framework offers a practical path to address a long-standing clinical challenge, balancing overtreatment against undertreatment in cN0 patients. With further validation, it may support safer surgical de-escalation and enable more personalized treatment strategies.
期刊介绍:
This journal aims to review the most important, recently published clinical findings in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those affected by cancer.
We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as cancer prevention, leukemia, melanoma, neuro-oncology, and palliative medicine. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.